Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Comparison and Evaluation of Different Methods for Uncertainty Quantification in Machine Learning | Katharina Juliane Lempe | Universität Leipzig, Medizinische Fakultät, Innovation Center Computer Assisted Surgery | PLCO | Dec 16, 2024 | PLCO-1763 |
| Comparison of multi-cancer early detection with LDCT in a lung cancer screening population | Jonathan Heiss | GRAIL, LLC | NLST | Feb 8, 2023 | NLST-1014 |
| Comparison of National Lung Cancer Resection Outcomes to Screening Trial Outcomes | Tyler Grenda | Sidney Kimmel Medical College, Thomas Jefferson University | NLST | Jan 27, 2020 | NLST-633 |
| Comparison of net endogenous acid production from dietary self-report instruments against recovery biomarker-derived measures | Douglas Chang | National Institute of Diabetes and Digestive and Kidney Diseases | IDATA | Mar 21, 2024 | IDATA-71 |
| Comparison of radiologist recommended follow-up with procedures received by study participants following screening with LDCT | Nana Boame | Brown University | NLST | Jun 22, 2020 | NLST-680 |
| Comparison of rates of radiological imaging in control arm of PLCO vs UK population | Matthew Callister | Leeds Teaching Hospitals NHS Trust | PLCO | Jul 9, 2013 | PLCO-39 |
| Comparison of self-reported water intake against recovery biomarkers | Douglas Chang | National Institute of Diabetes and Digestive and Kidney Diseases | IDATA | Mar 25, 2022 | IDATA-54 |
| Comparison of the PLCO data with the ovarian cancer screening data in Japan | Noriomi Matsumura | Kyoto University | PLCO | Jan 15, 2014 | PLCO-56 |
| Competing risks analysis of multiple cancers with application to vitamin D in PLCO | Yei Eun Shin | Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute | PLCO | Feb 2, 2022 | PLCO-904 |
| Competing risks model with application to lung cancer and breast cancer in PLCO | Minjung Lee | Kangwon National University | PLCO | Jun 6, 2023 | PLCO-1248 |
| Compliance and Mortality | Paul Pinsky | NCI | PLCO | Feb 2, 2017 | PLCO-255 |
| Components of survival time of screen detected cancer cases | Philip Prorok | NCI | NLST | Feb 3, 2015 | NLST-117 |
| Components of survival time of screen detected cancer cases | Philip Prorok | NCI | PLCO | Feb 3, 2015 | PLCO-129 |
| Comprehensive Analysis of Risk Factors and Predictive Modeling for Different Cancer types in the PLCO Dataset | Cheng He | Mirxes Labs Pte Ltd | PLCO | Dec 16, 2024 | PLCO-1768 |
| Comprehensive Lung Cancer Assessment via Deep Learning | Qian Li | VoxelCloud, inc. | NLST | Jan 10, 2018 | NLST-386 |
| Comprehensive Quality Management (CQM) in the PLCO Trial | Pam Marcus | NCI | PLCO | Sep 16, 2015 | PLCO-164 |
| Comprehensive Study of Interval Cancers | Robert Schoen | University of Pittsburgh | PLCO | Jul 1, 2006 | 2006-0227 |
| Comprehensive Tissue characterization with deep learning models utilizing NLST data for chest CT analysis | Damini Dey | APQ Health Inc | NLST | Sep 19, 2024 | NLST-1322 |
| Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification | Corey Arnold | University of California, Los Angeles | PLCO | Mar 11, 2024 | PLCOI-1492 |
| Computational Pathology in Ovarian Cancer | Sandra Orsulic | Regents University of California Los Angeles | PLCO | Dec 19, 2022 | PLCOI-1132 |